Related references
Note: Only part of the references are listed.Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: Lessons from neutrophils
Flavia Bazzoni et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The Predominant WT1 Isoform ( plus KTS) Encodes a DNA-Binding Protein Targeting the Planar Cell Polarity Gene Scribble in Renal Podocytes
Julie Wells et al.
MOLECULAR CANCER RESEARCH (2010)
WT1 the Oncogene: A Tale of Death and HtrA
Abdelkader Essafi et al.
MOLECULAR CELL (2010)
C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages
Mi-Jin Kim et al.
MOLECULES AND CELLS (2010)
IL-10 Inhibits Inflammation and Attenuates Left Ventricular Remodeling After Myocardial Infarction via Activation of STAT3 and Suppression of HuR
Prasanna Krishnamurthy et al.
CIRCULATION RESEARCH (2009)
The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells
Karin M. Kirschner et al.
FASEB JOURNAL (2008)
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene
Lina K. Martens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Stem cell-related cardiac gene expression early after murine myocardial infarction
Susanne Vandervelde et al.
CARDIOVASCULAR RESEARCH (2007)
The many facets of the Wilms' tumour gene, WT1
Peter Hohenstein et al.
HUMAN MOLECULAR GENETICS (2006)
Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene
Christof Dame et al.
BLOOD (2006)
Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1
N Wagner et al.
GENES & DEVELOPMENT (2005)
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games
T Hehlgans et al.
IMMUNOLOGY (2005)
Wilms' tumour: Connecting tumorigenesis and organ development in the kidney
MN Rivera et al.
NATURE REVIEWS CANCER (2005)
Tolerance and cancer: Mechanisms of tumor evasion and strategies for breaking tolerance
MY Mapara et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppress or WT1
N Wagner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
AP Vicari et al.
IMMUNOLOGICAL REVIEWS (2004)
cAMP-induced interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation
S Brenner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Induction of the interleukin-2/15 receptor β-chain by the EWS-WT1 translocation product
JC Wong et al.
ONCOGENE (2002)
Cytokines and immune response in the tumor microenvironment
S Mocellin et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Mechanisms of interleukin-10-mediated immune suppression
CA Akdis et al.
IMMUNOLOGY (2001)
Wilms' tumor gene WT1:: Its oncogenic function and clinical application
H Sugiyama
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells
C Platzer et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
